Christopher A. Czaja

1.7k total citations
22 papers, 1.0k citations indexed

About

Christopher A. Czaja is a scholar working on Epidemiology, Infectious Diseases and Rheumatology. According to data from OpenAlex, Christopher A. Czaja has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 7 papers in Infectious Diseases and 4 papers in Rheumatology. Recurrent topics in Christopher A. Czaja's work include Mycobacterium research and diagnosis (6 papers), Urinary Tract Infections Management (6 papers) and Tuberculosis Research and Epidemiology (5 papers). Christopher A. Czaja is often cited by papers focused on Mycobacterium research and diagnosis (6 papers), Urinary Tract Infections Management (6 papers) and Tuberculosis Research and Epidemiology (5 papers). Christopher A. Czaja collaborates with scholars based in United States, United Kingdom and France. Christopher A. Czaja's co-authors include Walter E. Stamm, Ann E. Stapleton, Thomas M. Hooton, T. M. Hooton, Pacita L. Roberts, Tina L. Fiedler, David N. Fredricks, Marsha Cox, Mansour Samadpour and Thomas R. Hawn and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Christopher A. Czaja

21 papers receiving 1.0k citations

Peers

Countries citing papers authored by Christopher A. Czaja

Since Specialization

Citations

This map shows the geographic impact of Christopher A. Czaja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Czaja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Czaja more than expected).

Fields of papers citing papers by Christopher A. Czaja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Czaja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Czaja. The network helps show where Christopher A. Czaja may publish in the future.

Co-authorship network of co-authors of Christopher A. Czaja

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Czaja. A scholar is included among the top collaborators of Christopher A. Czaja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Czaja. Christopher A. Czaja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clusters of emerging multidrug-resistant organisms in US health care facilities during the initial months of the SARS-CoV-2 pandemic 2024 ·American Journal of Infection Control ·(unknown), Ruoran Li, (unknown), Christopher A. Czaja, (unknown), (unknown), Melissa Cumming, (unknown), Gabriel K. Innes, (unknown), Allison Chan, Enyinnaya Merengwa, (unknown), Belinda Ostrowsky, Marie A. de Perio, Maroya Spalding Walters	1
2	Burkholderia multivorans Infections Associated with Use of Ice and Water from Ice Machines for Patient Care Activities ― Four Hospitals, California and Colorado, 2020–2024 2024 ·MMWR Morbidity and Mortality Weekly Report ·(unknown), Kevin B. Spicer, (unknown), Matthew J. Arduino, Paige Gable, Alison Laufer Halpin, Lindsay J. Caverly, John J. LiPuma, (unknown), (unknown), (unknown), Christopher A. Czaja, Raymond Chinn, Jane D. Siegel, Kiran M. Perkins	2
3	Notes from the Field: Potential Outbreak of Extrapulmonary Mycobacterium abscessus subspecies massiliense Infections from Stem Cell Treatment Clinics in Mexico — Arizona and Colorado, 2022 2024 ·MMWR Morbidity and Mortality Weekly Report ·Minh-Vu H Nguyen, Nabeeh A. Hasan, Vinicius Calado Nogueira de Moura, L. Elaine Epperson, Christopher A. Czaja, Helen Johnston, (unknown), (unknown), (unknown), (unknown), Marissa K. Grossman, Kiran M. Perkins, David E. Griffith, Reeti Khare, Michael Strong, Charles L. Daley	0
4	Incomplete tissue product tracing during an investigation of a tissue-derived tuberculosis outbreak 2023 ·American Journal of Transplantation ·Kristen E. Marshall, Rebecca J. Free, Thomas D. Filardo, Noah G. Schwartz, Alfonso C. Hernandez‐Romieu, Tyler C. Thacker, (unknown), Pallavi Annambhotla, (unknown), Janet Glowicz, (unknown), (unknown), Christopher A. Czaja, Sridhar V. Basavaraju	1
5	Epidemiology of Pulmonary and Extrapulmonary Nontuberculous Mycobacteria Infections at 4 US Emerging Infections Program Sites: A 6-Month Pilot 2023 ·Clinical Infectious Diseases ·Cheri Grigg, Kelly A. Jackson, Devra Barter, Christopher A. Czaja, Helen Johnston, Ruth Lynfield, Paula Snippes Vagnone, (unknown), Nancy Spina, Ghinwa Dumyati, P. Maureen Cassidy, Rebecca Pierce, Emily Henkle, D. Rebecca Prevots, Max Salfinger, Kevin Winthrop, (unknown), Shelley S. Magill	24
6	Association of Clostridioides difficile infection rates with social determinants of health in Denver area census tracts, 2016–2019 2023 ·Preventive Medicine Reports ·(unknown), (unknown), Helen Johnston, Mary Casey, (unknown), Alison G. Abraham, Christopher A. Czaja	3
7	Impact of the coronavirus disease 2019 (COVID-19) pandemic on antimicrobial stewardship programs in Colorado hospitals 2022 ·SHILAP Revista de lepidopterología ·(unknown), Christopher A. Czaja, Matthew P. Kronman, Sonja I. Ziniel, Sarah K. Parker, (unknown)	2
8	Nursing Home Adoption of CDC and ASHRAE COVID-19 Built Environment Recommendations: A Characterization Study of Colorado Nursing Home Facilities 2022 ·HERD Health Environments Research & Design Journal ·(unknown), Christopher A. Czaja, (unknown), Mike Van Dyke	1
9	Health care personnel exposures to subsequently laboratory-confirmed monkeypox patients — Colorado, 2022 2022 ·American Journal of Transplantation ·Kristen E. Marshall, (unknown), Janell Nichols, Marie A. de Perio, (unknown), Emily Spence-Davizon, Meghan Barnes, Rachel Herlihy, Christopher A. Czaja	4
10	The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic 2021 ·Clinical Infectious Diseases ·Emma E. Seagle, Brendan R. Jackson, Shawn R. Lockhart, (unknown), Natalie S. Nunnally, Jeremy Roland, Devra M. Barter, Helen Johnston, Christopher A. Czaja, (unknown), Paula Clogher, (unknown), Monica M. Farley, Lee H. Harrison, Sarah Shrum Davis, Erin C. Phipps, Brenda L. Tesini, William Schaffner, Tiffanie Markus, Meghan Lyman	98
11	Evaluation of rates of laboratory-confirmed influenza hospitalization in rural and urban census tracts over eight influenza seasons 2020 ·Preventive Medicine ·Christopher A. Czaja, Myles Cockburn, Kathryn Colborn, Lisa A. Miller, Deborah S.K. Thomas, Rachel Herlihy, Nisha B. Alden, Eric A. F. Simões	3
12	State‐level estimates of excess hospitalizations and deaths associated with influenza 2019 ·Influenza and Other Respiratory Viruses ·Christopher A. Czaja, Lisa A. Miller, Kathryn Colborn, Myles Cockburn, Nisha B. Alden, Rachel Herlihy, Eric A. F. Simões	10
13	Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort Study 2015 ·Annals of the American Thoracic Society ·Christopher A. Czaja, Adrah Levin, Christian W. Cox, Daniel Vargas, Charles L. Daley, Gary R. Cott	41
14	Rituximab as Successful Adjunct Treatment in a Patient With Disseminated Nontuberculous Mycobacterial Infection Due to Acquired Anti-Interferon- Autoantibody 2013 ·Clinical Infectious Diseases ·Christopher A. Czaja, Patricia Merkel, Edward D. Chan, Laurel Lenz, (unknown), R. Alam, Stanley Frankel, Aryeh Fischer, (unknown), Carlos M. Pérez‐Vélez, Vernon Knight	59
15	Randomized, Placebo-Controlled Phase 2 Trial of a Lactobacillus crispatus Probiotic Given Intravaginally for Prevention of Recurrent Urinary Tract Infection 2011 ·Clinical Infectious Diseases ·Ann E. Stapleton, (unknown), Thomas M. Hooton, David N. Fredricks, Pacita L. Roberts, Christopher A. Czaja, (unknown), Tina L. Fiedler, Marsha Cox, Walter E. Stamm	339
16	Urinary Tract Infections in Women With Type 1 Diabetes Mellitus: Survey of Female Participants in the Epidemiology of Diabetes Interventions and Complications Study Cohort 2009 ·The Journal of Urology ·Christopher A. Czaja, Brandy Rutledge, Patricia A. Cleary, K. Chan, Ann E. Stapleton, Walter E. Stamm	27
17	Prospective Cohort Study of Microbial and Inflammatory Events Immediately PrecedingEscherichia coliRecurrent Urinary Tract Infection in Women 2009 ·The Journal of Infectious Diseases ·Christopher A. Czaja, Walter E. Stamm, Ann E. Stapleton, Pacita L. Roberts, Thomas R. Hawn, D. Scholes, Mansour Samadpour, Scott J. Hultgren, Thomas M. Hooton	93
18	Phase I Trial of aLactobacillus crispatusVaginal Suppository for Prevention of Recurrent Urinary Tract Infection in Women 2007 ·Infectious Diseases in Obstetrics and Gynecology ·Christopher A. Czaja, Ann E. Stapleton, (unknown), Walter E. Stamm	71
19	Population-Based Epidemiologic Analysis of Acute Pyelonephritis 2007 ·Clinical Infectious Diseases ·Christopher A. Czaja, (unknown), T. M. Hooton, Walter E. Stamm	218
20	Update on acute uncomplicated urinary tract infection in women 2006 ·Postgraduate Medicine ·Christopher A. Czaja, Thomas M. Hooton	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact